Section 5-405 - Schedule IV. - Maryland Statutes

§ 5-405. Schedule IV.
 

(a)  In general.- Schedule IV consists of each controlled dangerous substance: 

(1) listed in this section; 

(2) added to Schedule IV by the Department under § 5-202(b) of this title; or 

(3) designated as a Schedule IV controlled dangerous substance by the federal government unless the Department objects under § 5-202(f) of this title. 

(b)  Core substances.- Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system: 

(1) barbital; 

(2) bromazepam; 

(3) camazepam; 

(4) chloral betaine; 

(5) chloral hydrate; 

(6) ethchlorvynol; 

(7) chlordiazepoxide; 

(8) clobazam; 

(9) clonazepam; 

(10) clorazepate; 

(11) clotiazepam; 

(12) cloxazolam; 

(13) delorazepam; 

(14) diazepam; 

(15) estazolam; 

(16) ethinamate; 

(17) ethylloflazepate; 

(18) fludiazepam; 

(19) flunitrazepam; 

(20) flurazepam; 

(21) halazepam; 

(22) haloxazolam; 

(23) ketazolam; 

(24) loprazolam; 

(25) lorazepam; 

(26) lormetazepam; 

(27) mebutamate; 

(28) medazepam; 

(29) methohexital; 

(30) meprobamate; 

(31) methylphenobarbital; 

(32) nimetazepam; 

(33) nitrozepam; 

(34) nordiazepam; 

(35) oxazepam; 

(36) oxazolam; 

(37) paraldehyde; 

(38) petrichloral; 

(39) phenobarbital; 

(40) pinazepam; 

(41) prazepam; 

(42) temazepam; 

(43) tetrazepam; and 

(44) triazolam. 

(c)  Fenfluramine.- Substances listed in Schedule IV include: 

(1) a material, compound, mixture, or preparation that contains fenfluramine; and 

(2) if its existence is possible: 

(i) a salt of fenfluramine; 

(ii) an optical, position, or geometric isomer of fenfluramine; and 

(iii) a salt of an isomer of fenfluramine. 

(d)  Stimulants.- Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system: 

(1) diethylpropion; 

(2) pemoline, including organometallic complexes and their chelates; and 

(3) phentermine. 

(e)  Exemptions.- By regulation, the Department may exempt from this section a compound, mixture, or preparation that contains a depressant substance listed in subsection (b) of this section if: 

(1) the compound, mixture, or preparation contains an active medicinal ingredient that does not have a depressant effect on the central nervous system; and 

(2) the admixtures are included in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system. 

(f)  Required factors for adding substance.- The Department may not add a substance to Schedule IV under § 5-202 of this subtitle unless the Department finds that: 

(1) the substance has a low potential for abuse relative to the substances listed in Schedule III; 

(2) the substance has currently accepted medical use in treatment in the United States; and 

(3) abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances in Schedule III. 
 

[An. Code 1957, art. 27, § 279(d); 2002, ch. 26, § 2; 2003, ch. 21, § 1.]